Results 151 to 160 of about 4,121 (173)
Some of the next articles are maybe not open access.
E100 Comparison between BASDAI and ASDAS c-reactive protein scores in spondyloarthritis
RheumatologyAbstract Background/Aims The choice between evaluation indices for disease activity in spondyloarthritis (SpA) in daily practice can be challenging due to the highly heterogeneous clinical expression of the disease.
Mohammed Khalil Jnyah +3 more
openaire +1 more source
BASDAI cut-off values corresponding to ASDAS cut-off values
Rheumatology, 2022Oh Chan Kwon +2 more
exaly
Zeitschrift fur Rheumatologie, 2004
The purpose of this study was the validation of a German translation of the Bath Ankylosing Spondylitis Index (BASDAI).The German translation of the BASDAI was validated using data of 134 patients with ankylosing spondylitis (AS) from a spondyloarthropathy cohort. For validation the BASDAI was compared with parameters assessed by physicians (physicians
J, Brandt +6 more
openaire +1 more source
The purpose of this study was the validation of a German translation of the Bath Ankylosing Spondylitis Index (BASDAI).The German translation of the BASDAI was validated using data of 134 patients with ankylosing spondylitis (AS) from a spondyloarthropathy cohort. For validation the BASDAI was compared with parameters assessed by physicians (physicians
J, Brandt +6 more
openaire +1 more source
Zeitschrift fur Rheumatologie, 2004
Translation and validation of the Bath Ankylosing Spondylitis Disease Activity Index ( BASDAI) for defining disease status in ankylosing spondylitis (AS) and related diseases.The German version BASDAI-D was translated with only a few modifications.
A, Bönisch, I, Ehlebracht-König
openaire +1 more source
Translation and validation of the Bath Ankylosing Spondylitis Disease Activity Index ( BASDAI) for defining disease status in ankylosing spondylitis (AS) and related diseases.The German version BASDAI-D was translated with only a few modifications.
A, Bönisch, I, Ehlebracht-König
openaire +1 more source
Annals of the Rheumatic Diseases, 2022
S. Byravan, S. Jothimurugan, A. Moorthy
openaire +1 more source
S. Byravan, S. Jothimurugan, A. Moorthy
openaire +1 more source

